These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

971 related items for PubMed ID: 17020405

  • 1. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance.
    Cox H, Kebede Y, Allamuratova S, Ismailov G, Davletmuratova Z, Byrnes G, Stone C, Niemann S, Rüsch-Gerdes S, Blok L, Doshetov D.
    PLoS Med; 2006 Oct; 3(10):e384. PubMed ID: 17020405
    [Abstract] [Full Text] [Related]

  • 2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 3. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance.
    Cox HS, Niemann S, Ismailov G, Doshetov D, Orozco JD, Blok L, Rüsch-Gerdes S, Kebede Y.
    Clin Infect Dis; 2007 Jun 01; 44(11):1421-7. PubMed ID: 17479936
    [Abstract] [Full Text] [Related]

  • 4. Tuberculosis drug resistance and treatment outcomes under DOTS settings in large cities in the Philippines.
    Ohkado A, Aguiman L, Adlawan S, Baring E, Quirante O, Suchi M, Endo S, Fujiki A, Mori T.
    Int J Tuberc Lung Dis; 2006 Mar 01; 10(3):283-9. PubMed ID: 16562708
    [Abstract] [Full Text] [Related]

  • 5. [Drug resistance of Mycobacterium tuberculosis in Orizaba, Veracruz. Implications for the tuberculosis prevention and control program].
    García-García ML, Sifuentes-Osornio J, Jiménez-Corona ME, Ponce-de-León A, Jiménez-Corona A, Bobadilla-del Valle M, Palacios-Martínez M, Canales G, Sanginés A, Jaramillo Y, Martínez-Gamboa A, Balandrano S, Valdespino-Gómez JL, Small P.
    Rev Invest Clin; 2001 Mar 01; 53(4):315-23. PubMed ID: 11599478
    [Abstract] [Full Text] [Related]

  • 6. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes.
    Yoshiyama T, Yanai H, Rhiengtong D, Palittapongarnpim P, Nampaisan O, Supawitkul S, Uthaivorawit W, Mori T.
    Int J Tuberc Lung Dis; 2004 Jan 01; 8(1):31-8. PubMed ID: 14974743
    [Abstract] [Full Text] [Related]

  • 7. Rifampicin mono-resistant Mycobacterium tuberculosis in Bujumbura, Burundi: results of a drug resistance survey.
    Sanders M, Van Deun A, Ntakirutimana D, Masabo JP, Rukundo J, Rigouts L, Fissette K, Portaelst F.
    Int J Tuberc Lung Dis; 2006 Feb 01; 10(2):178-83. PubMed ID: 16499257
    [Abstract] [Full Text] [Related]

  • 8. [The short-term and long-term treatment outcomes in patients with pulmonary tuberculosis positive for drug-resistant and sensitive strains].
    Han JP, Sun SL, Li RZ, Zhang FS, Wang SC, Cheng J, Deng YF, Wang Y, Yu CB.
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb 01; 26(2):70-3. PubMed ID: 12783654
    [Abstract] [Full Text] [Related]

  • 9. Encouraging outcomes in the first year of a TB control demonstration program: Orel Oblast, Russia.
    Kherosheva T, Thorpe LE, Kiryanova E, Rybka L, Gerasichev V, Shulgina M, Nemtsova E, Aptekar T, Kluge H, Jakubowiak W, Grzemska M, Aquino G, Wells C, Kazionny B.
    Int J Tuberc Lung Dis; 2003 Nov 01; 7(11):1045-51. PubMed ID: 14598963
    [Abstract] [Full Text] [Related]

  • 10. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
    Ratsirahonana O, Rasolofo Razanamparany V, Rasolonavalona T, Rakotonirina V, Rakotoarisaonina A, Rakotoherisoa A, Ralamboson M, Cauchoix B, Rakotondramarina D, Ramarokoto H.
    Arch Inst Pasteur Madagascar; 2002 Nov 01; 68(1-2):44-7. PubMed ID: 12643091
    [Abstract] [Full Text] [Related]

  • 11. Multidrug-resistant tuberculosis in central Asia.
    Cox HS, Orozco JD, Male R, Ruesch-Gerdes S, Falzon D, Small I, Doshetov D, Kebede Y, Aziz M.
    Emerg Infect Dis; 2004 May 01; 10(5):865-72. PubMed ID: 15200821
    [Abstract] [Full Text] [Related]

  • 12. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar 01; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

  • 13. [Research and control of relapse tuberculosis cases].
    Yamagishi F, Toyota M.
    Kekkaku; 2009 Dec 01; 84(12):767-8. PubMed ID: 20077861
    [Abstract] [Full Text] [Related]

  • 14. [Impact of anti-tuberculosis drug resistance on treatment outcome of pulmonary tuberculosis patients receiving directly observed treatment strategy in Henan Province, China].
    Wang GJ, Xu JY, Wang GB, Zhen XA, Gao SY, Du CM.
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug 01; 29(8):527-30. PubMed ID: 17074265
    [Abstract] [Full Text] [Related]

  • 15. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
    Elliott AM, Halwiindi B, Hayes RJ, Luo N, Mwinga AG, Tembo G, Machiels L, Steenbergen G, Pobee JO, Nunn PP.
    J Trop Med Hyg; 1995 Feb 01; 98(1):9-21. PubMed ID: 7861484
    [Abstract] [Full Text] [Related]

  • 16. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
    Reechaipichitkul W.
    Southeast Asian J Trop Med Public Health; 2002 Sep 01; 33(3):570-4. PubMed ID: 12693593
    [Abstract] [Full Text] [Related]

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 01; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 18. Antituberculosis drug resistance in the south of Vietnam: prevalence and trends.
    Huong NT, Lan NT, Cobelens FG, Duong BD, Co NV, Bosman MC, Kim SJ, van Soolingen D, Borgdorff MW.
    J Infect Dis; 2006 Nov 01; 194(9):1226-32. PubMed ID: 17041848
    [Abstract] [Full Text] [Related]

  • 19. Mycobacterium tuberculosis in Taiwan.
    Hsueh PR, Liu YC, So J, Liu CY, Yang PC, Luh KT.
    J Infect; 2006 Feb 01; 52(2):77-85. PubMed ID: 16216328
    [Abstract] [Full Text] [Related]

  • 20. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M, Marjani M, Chitsaz E, Kazempour M, Esmaeili M, Farnia P, Tabarsi P, Amiri MV, Mirsaeidi M, Mansouri D, Masjedi MR, Velayati AA.
    Int J Infect Dis; 2009 Sep 01; 13(5):e236-40. PubMed ID: 19285897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.